Bank of America’s Intersect ENT, Inc XENT Stock Holding History

Bank of America’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-41,000	Closed	-$1.02M	–	7424
2019 Q4	$1.02M	Buy	+41,000	New	+$831K	﹤0.01%	4498
2018 Q1	–	Sell	-32,700	Closed	-$1.06M	–	7434
2017 Q4	$1.06M	Sell	32,700 -6,300	-16%	-$189K	﹤0.01%	4456
2017 Q3	$1.22M	Buy	+39,000	New	+$1.15M	﹤0.01%	4376
2016 Q3	–	Sell	-40,000	Closed	-$517K	–	7455
2016 Q2	$517K	Buy	+40,000	New	+$626K	﹤0.01%	4644

Bank of America's XENT Position: Q2 2022 in Review

Bank of America sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 572,442 shares — an estimated $16M sold.

Bank of America first reported a position in XENT in Q1 2015 and held it in 29 quarters. The position peaked at $16M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Bank of America reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Bank of America sold 572,442 Intersect ENT, Inc shares in Q2 2022, an estimated $16M.
Bank of America first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 29 quarters.
Bank of America's Intersect ENT, Inc position peaked at $16M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Bank of America's 13F filing for Q2 2022, filed 12 Aug 2022.